Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Checking Bulk Appearance and Clarity – V 2.0

Posted on By

Elixir Department: SOP for Checking Bulk Appearance and Clarity – V 2.0

Standard Operating Procedure for Checking Bulk Appearance and Clarity in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/102/2025
Supersedes SOP/ELX/102/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To outline the procedure for checking the appearance and clarity of bulk elixir before it proceeds for filtration, storage, or bottling, ensuring compliance with visual and organoleptic quality parameters.

2. Scope

This SOP applies to all elixir batches manufactured in the Elixir Department that require visual inspection for appearance, color, clarity, and the presence of visible particles.

3. Responsibilities

  • Production Operator:
    • Collect samples and perform initial visual checks.
  • Production Supervisor:
    • Verify appearance results and document observations in the BMR.
  • QA Officer:
    • Confirm observations, verify specifications, and approve the batch for the next stage.
See also  Elixir Department: SOP for Refractive Index Determination - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring that all bulk elixir batches are evaluated for appearance and clarity before release for further processing.

5. Procedure

5.1 Sample Collection

  1. After final mixing, collect 100
mL of bulk solution using a sanitized sampling beaker.
  • Ensure that the sample is representative and taken from the middle layer of the tank.
  • Transfer the sample into a clean, transparent glass bottle for visual examination.
  • 5.2 Visual Inspection

    1. Inspect the sample against white and black backgrounds under adequate lighting (minimum 600 lux).
    2. Observe and record the following attributes:
      • Appearance: Clear, colored, or turbid
      • Color: As per product specification (e.g., pink, yellow)
      • Clarity: Clear / Slightly hazy / Opaque
      • Visible Particles: Absent / Present (e.g., fibers, foreign matter)
    3. If any visible particulate matter or turbidity is observed, escalate for re-filtration or investigation.

    5.3 Specification Comparison

    1. Compare observed characteristics with approved specification limits as mentioned in the product master formula or QC specification.
    2. Record any deviations in the Appearance and Clarity Log (Annexure-1) and report to QA immediately.

    5.4 Approval and Documentation

    1. QA shall verify the recorded results and sign off if the batch complies with clarity and appearance requirements.
    2. Production shall record details in the BMR and attach the Appearance and Clarity Log (Annexure-1).

    6. Abbreviations

    • SOP: Standard Operating Procedure
    • BMR: Batch Manufacturing Record
    • QA: Quality Assurance

    7. Documents

    1. Appearance and Clarity Log (Annexure-1)
    2. Batch Manufacturing Record (BMR)

    8. References

    • Pharmacopoeial Guidelines (IP, USP, BP)
    • WHO TRS 986 – GMP for Pharmaceutical Products
    • 21 CFR Part 211.160 – General Requirements for Laboratory Controls

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Appearance and Clarity Log

    Date Batch No. Appearance Color Clarity Particles Observed By QA Verified
    11/04/2025 ELX-1041 Clear Pale Yellow Clear Absent Rajesh Kumar Sunita Reddy

    Revision History:

    Revision Date Revision No. Revision Details Reason for Revision Approved By
    01/01/2024 1.0 Initial SOP Release New SOP QA Head
    11/04/2025 2.0 Refined inspection process and included visual backgrounds Visual QC Enhancement QA Head
    See also  Elixir Department: SOP for Homogeneity Verification - V 2.0
    Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

    Post navigation

    Previous Post: Biosimilars: SOP for Tank-to-Tank Transfer of Cultures – V 2.0
    Next Post: API Manufacturing: SOP for Issuance and Control of Logbooks – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Gels V 2.0
    • Injectables V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version